Shopping Cart
- Remove All
Your shopping cart is currently empty
Robatumumab
🥰Excellent
Catalog No. T76759Cas No. 934235-44-6
Alias School 717454, Sch717454, Sch 717454, MK-7454, MK7454, 19D12
Robatumumab (Sch 717454) is a fully human anti-insulin-like growth factor receptor type 1 (IGF-1R) monoclonal antibody with antitumor and antiproliferative activity.Robatumumab is used in the study of ovarian cancer.
Robatumumab
Robatumumab
🥰Excellent
Purity: 95%
Catalog No. T76759Alias School 717454, Sch717454, Sch 717454, MK-7454, MK7454, 19D12Cas No. 934235-44-6
Robatumumab (Sch 717454) is a fully human anti-insulin-like growth factor receptor type 1 (IGF-1R) monoclonal antibody with antitumor and antiproliferative activity.Robatumumab is used in the study of ovarian cancer.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $189 | In Stock | |
| 5 mg | $479 | In Stock | |
| 10 mg | $768 | In Stock | |
| 25 mg | $1,150 | In Stock | |
| 50 mg | $1,550 | In Stock |
Bulk & Custom
Add to Cart
Questions
View MoreInhibitors Related to "Robatumumab"
Indirubin Derivative E804
T11654854171-35-0In house
Indirubin Derivative E804 is a potent insulin-like growth factor type 1 receptor (IGF1R) inhibitor with potential antitumor activity.
- $58
Size
QTY
Ceritinib
Cited
LDK378
T17911032900-25-6
Ceritinib (LDK378) is an ALK tyrosine kinase inhibitor (IC50=200 pM) with selective, ATP-competitive, and oral activity. Ceritinib also inhibits IGF-1R, InsR, and STK22D (IC50=8/7/23 nM). Ceritinib has antitumor activity.
- $45
Size
QTY
CitedALK-IN-1
Brigatinib-analog, AP26113-analog, AP26113
T30591197958-12-5
ALK-IN-1 (AP26113) is a potent ALK inhibitor with IC50 of 0.62 nM in a cell-free assay, demonstrated ability overcome Crizotinib resistance mediated by a L1196M mutation. Phase 2.
- $40
Size
QTY
HNMPA
T21761132541-52-7In house
HNMPA is a membrane impermeable inhibitor of insulin receptor tyrosine kinase. HNMPA inhibits tyrosine and serine autophosphorylation by the human insulin receptor. HNMPA exhibits no effect on cyclic AMP-dependent protein kinase or protein kinase C activities.
- $43
Size
QTY
PD173074 Cited
T2642219580-11-7
PD173074 is an effective FGFR1 inhibitor (IC50: 25 nM) and also inhibits VEGFR2 (IC50: 100-200 nM) in cell-free assays. The selectivity is higher ~1000-fold for FGFR1 than PDGFR and c-Src.
- $36
Size
QTY
CitedBrigatinib Cited
AP-26113
T36211197953-54-0
Brigatinib (AP-26113) is a highly potent and selective inhibitor of ALK.
- $30
Size
QTY
CitedTyrphostin AG 538
AG 538
T67707133550-18-2In house
Tyrphostin AG 538 is a chalcone compound, an IGF-1 receptor kinase inhibitor (IC₅0 : for 400 nM) that is potent, cell-permeable, reversible, and competitive.
- $100
Size
QTY
Insulin (human)
Cited
Insulin(human), INSULIN
T822111061-68-0
Insulin (human) is a peptide hormone that promotes glycogen synthesis and regulates glucose levels in the blood. Insulin (human) has hypoglycemic activity and is used clinically to treat hyperglycemia in diabetic patients.
- $30
Size
QTY
CitedLinsitinib Cited
OSI-906
T6017867160-71-2
OSI-906 (Linsitinib (OSI-906)) is an orally bioavailable small molecule inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) with potential antineoplastic activity. Linsitinib selectively inhibits IGF-1R, which may result in the inhibition of tumor cell proliferation and the induction of tumor cell apoptosis. Overexpressed in a variety of human cancers, IGF-1R stimulates cell proliferation, enables oncogenic transformation, and suppresses apoptosis.
- $33
Size
QTY
CitedI-OMe-Tyrphostin AG 538
I-OMe-AG 538
T115931094048-77-7In house
I-OMe-Tyrphostin AG 538 is a specific IGF-1R inhibitor and ATP-competitive inhibitor of PI5P4Kα (IC50: 1 µM).I-OMe-Tyrphostin AG 538 inhibits IGF-1R-mediated signaling and exhibits preferential cytotoxicity to nutrient-deficient PANC1 cells.
- $51
Size
QTY
Picropodophyllin Cited
PPP, Picropodophyllotoxin, AXL1717
T6943477-47-4
Picropodophyllin (Picropodophyllin (PPP)) (PPP) is a specific IGF-1R inhibitor (IC50: 1 nM). Picropodophyllin specifically inhibits the activity and downregulates the cellular expression of IGF1R without interfering with activities of other growth factor receptors, such as receptors for insulin, epidermal growth factor, platelet-derived growth factor, fibroblast growth factor and mast/stem cell growth factor (KIT).
- $58
Size
QTY
CitedSelect Batch
Concentration:6.35 mg/mL
Purity:95%
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Chemical Properties
| Description | Robatumumab (Sch 717454) is a fully human anti-insulin-like growth factor receptor type 1 (IGF-1R) monoclonal antibody with antitumor and antiproliferative activity.Robatumumab is used in the study of ovarian cancer. |
| In vitro | Robatumumab (0.02-80 nM; 0.5 or 4 hours) inhibited basal and IGF-I-induced phosphorylation of IGF-IR and IRS-1 in SK-N-FI cells by decreasing IGF-IR expression levels. [2] |
| In vivo | Robatumumab (i.v.; 0.04 or 0.1 mg/mouse; twice weekly; 18 days total) reduced SK-N-FI tumor growth in a xenograft model. [2] Robatumumab (i.v.; 0.02-0.5 mg/mouse; twice weekly; 35 days) was effective in inhibiting osteosarcoma expansion in a xenograft model. [2] Robatumumab (i.v.; 0.1 or 0.5 mg/mouse; twice weekly; 14 days) significantly inhibited the proliferation of SJCRH30 and RD rhabdomyosarcoma cells in a xenograft model. [2] Robatumumab (intravenous; 0.1 or 0.5 mg/mouse; twice weekly; 2 weeks) effectively blocked the growth of pediatric tumor cells in vivo. [2] Robatumumab (i.v.; 0.5 mg/mouse; single dose; day 11 post-vaccination) regulates blood vessel formation by exerting anti-angiogenic effects. [2] |
| Alias | School 717454, Sch717454, Sch 717454, MK-7454, MK7454, 19D12 |
| Cas No. | 934235-44-6 |
Storage & Solubility Information
| Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Robatumumab | purchase Robatumumab | Robatumumab cost | order Robatumumab | Robatumumab in vivo | Robatumumab in vitro
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.